Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis
Anticancer Research · 2025-05 · 45 (5) · 2059-2069
DOI: 10.21873/anticanres.17580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 28.04.2025. Verfasst von Jan Leppert und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Medical Center Schleswig-Holstein/Lübeck, Lübeck, Germany; jan.leppert@uksh.de. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND/AIM: Glioblastoma is more common in men than in women. The aim of this analysis was to investigate sex-specific differences with a particular focus on their impact on survival including overall survival (OS) and progression-free survival (PFS). PATIENTS AND METHODS: This retrospective study analyzed 209 GBM patients (91 females, 118 males) treated according to the Stupp regimen. Data on patient demographics, O6-methylguanine-DNA methyltransferase (MGMT) methylation status, treatment details [radiotherapy (RT) doses and temozolomide (TMZ) cycles], and survival endpoints were statistically analyzed using univariable Kaplan-Meier [and 95% confidence intervals (CI)] and multivariable Cox regression hazards models. RESULTS: In the whole cohort, median follow-up was 14 (2-119) months. We observed a trend towards a higher prevalence of multifocal tumors in males (30.5% vs. 22%, p=0.092). In univariable analysis, MGMT-negative male patients who received >58 Gy RT had a significantly longer OS (14 vs. 5 months, log-rank p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, University Medical Center Schleswig-Holstein/Lübeck, Lübeck, Germany; jan.leppert@uksh.de.
- Department of Neurosurgery, University Medical Center Schleswig-Holstein/Lübeck, Lübeck, Germany.
- Department of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Radiotherapy, University Medical Center Schleswig-Holstein/Lübeck, Lübeck, Germany.
- Tetra Pak Processing GmbH, Reinbek, Germany.
- State Institution Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.
Zitieren
APA
Leppert, J., Ditz, C., Matschke, J., Krenzlin, H., Keric, N., Ziemann, C., Hahn, L., Matone, M. V., Liubich, L., Streubel, K., Schacht, H., Hillbricht, C., Kuppler, P., Rades, D., & Löser, A. (2025). Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis. Anticancer Research, 45(5), 2059-2069. https://doi.org/10.21873/anticanres.17580
Vancouver
Leppert J, Ditz C, Matschke J, Krenzlin H, Keric N, Ziemann C, et al. Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis. Anticancer Research. 2025;45(5):2059-2069. doi:10.21873/anticanres.17580
BibTeX
@article{Leppert2025,
author = {Leppert, Jan and Ditz, Claudia and Matschke, Jakob and Krenzlin, Harald and Keric, Naureen and Ziemann, Christian and Hahn, Lorenz and Matone, Maria Vittoria and Liubich, Larysa and Streubel, Karolin and Schacht, Hannes and Hillbricht, Christina and Kuppler, Patrick and Rades, Dirk and Löser, Anastassia},
title = {Sex-related Survival Differences in Patients With Glioblastoma – Results From a Retrospective Analysis},
journal = {Anticancer Research},
year = {2025},
volume = {45},
number = {5},
pages = {2059--2069},
doi = {10.21873/anticanres.17580}
}
EUVIMED